Optimizing HER2-Positive Breast Cancer Therapy: Balancing Efficacy and Toxicity

Optimizing Treatment of Metastatic G/GEJ Cancers: Balancing Efficacy and Adverse Effects With Com...Подробнее

New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Mahtani & Dr. SchwartzbergПодробнее

Optimizing Therapy for HER2-Positive Breast Cancer Study (CompassHER2-pCR)Подробнее

Optimizing Therapy in HER2+ Disease with Dr. Kevin KalinskyПодробнее

Optimizing Therapy in HER2+ Disease with Dr. Hope S. RugoПодробнее

Optimizing treatment in patients with early-stage HER2-positive breast cancerПодробнее

Optimizing Therapy in HER2+ Disease with Dr. Reshma MahtaniПодробнее

Optimizing Therapy in HER2+ Disease with Dr. Alvaro Moreno-AspitiaПодробнее

I'm Living Proof You Can THRIVE with HER2 Positive Breast CancerПодробнее

Spotlight Poster Discussion: "Optimizing use of HER2 therapies in metastatic HER2+ breast..."Подробнее

Optimizing adjuvant treatment in HR+/HER2- early breast cancerПодробнее

New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Bagegni & Dr. GradisharПодробнее

Sramila Aithal, MD | Neratinib and Dose Escalation | Optimizing Therapy for HER2+ DiseaseПодробнее

Treatment optimization trials in breast cancerПодробнее

New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Irene and Dr. VogelПодробнее

Optimizing adjuvant therapy: chemotherapy necessity in HR-positive breast cancerПодробнее

New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Meisel & Dr. SolimanПодробнее

New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Kaklamani and Dr. O’ReganПодробнее

New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Traina & Dr. CareyПодробнее